{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:37:37Z","timestamp":1774438657477,"version":"3.50.1"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Chordomas of the spine and sacrum are a rare but debilitating cancer and require complex multidisciplinary care. Studies of other such rare cancers have demonstrated an association of high-volume and\/or multidisciplinary centers with improved outcomes and survival. Such an association has been proposed for chordomas, but evidence to support this claim is lacking. The authors performed a study to investigate if treatment facility type is associated with patterns of care and survival for patients with spinal and sacral chordomas by assessing records from a US-based cancer database.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>In this observational retrospective cohort study, the authors identified 1266 patients from the National Cancer Database with vertebral column or sacral chordomas diagnosed between 2004 and 2015. The primary study outcome was overall survival, and secondary outcomes included odds of receiving treatment and time to treatment, defined as radiation therapy, surgery, and\/or any treatment, including surgery, radiation therapy, chemotherapy, or participation in clinical trials. The results were adjusted for age, sex, race\/ethnicity, level of education, income, and Charlson\/Deyo score.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Of the 1266 patients identified, the mean age at diagnosis was 59.70 years (SD 16.2 years), and the patients were predominantly male (n = 791 [62.50%]). Patients treated at community cancer programs demonstrated an increased risk of death (HR 1.98, 95% CI 1.13\u20133.47, p = 0.018) when compared to patients treated at academic\/research programs (ARPs). The median survival was longest for those treated at ARPs (131.45 months) compared to community cancer programs (79.34 months, 95% CI 48.99\u2013123.17) and comprehensive community cancer programs (CCCPs) (109.34 months, 95% CI 84.76\u2013131.45); 5-year survival rates were 76.08%, 52.71%, and 61.57%, respectively. Patients treated at community cancer programs and CCCPs were less likely to receive any treatment compared to those treated at ARPs (OR 6.05, 95% CI 2.62\u201313.95, p &lt; 0.0001; OR 3.74, 95% CI 2.23\u20136.28, p &lt; 0.0001, respectively). Patients treated at CCCPs and community cancer programs were less likely to receive surgery than those treated at ARPs (OR 2.69, 95% CI 1.82\u20133.97, p = 0.010; OR = 2.64, 95% CI 1.22\u20135.71, p = 0.014, respectively). Patients were more likely to receive any treatment (OR 0.59, 95% CI 0.40\u20130.87, p = 0.007) and surgery (OR 0.58, 95% CI 0.38\u20130.88, p &lt; 0.0001) within 30 days at a CCCP compared to an ARP. There were no differences in odds of receiving radiation therapy or time to radiation by facility type.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Clinical care at an ARP is associated with increased odds of receiving treatment that is associated with improved overall survival for patients with spinal and sacral chordomas, suggesting that ARPs provide the most comprehensive specialized care for patients with this rare and devastating oncological disease.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2019.7.spine19566","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T22:56:16Z","timestamp":1572648976000},"page":"311-320","source":"Crossref","is-referenced-by-count":20,"title":["Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015"],"prefix":"10.3171","volume":"32","author":[{"given":"Christina Huang","family":"Wright","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Department of Neurosurgery, Case Western Reserve University;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Department of Neurosurgery, Case Western Reserve University;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Cioffi","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center and Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio; and"},{"name":"Central Brain Tumor Registry of the United States, Hinsdale, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Hdeib","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Department of Neurosurgery, Case Western Reserve University;"},{"name":"Seidman Cancer Center and Case Comprehensive Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish K.","family":"Kasliwal","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Department of Neurosurgery, Case Western Reserve University;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Kruchko","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States, Hinsdale, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill S.","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center and Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio; and"},{"name":"Central Brain Tumor Registry of the United States, Hinsdale, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Sloan","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals Cleveland Medical Center;"},{"name":"Department of Neurosurgery, Case Western Reserve University;"},{"name":"Seidman Cancer Center and Case Comprehensive Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","article-title":"Aetna: Proton beam, neutron beam, and carbon ion radiotherapy","unstructured":"Aetna: Proton beam, neutron beam, and carbon ion radiotherapy. Aetna.com. July 29, 2019 (http:\/\/www.aetna.com\/cpb\/medical\/data\/200_299\/0270.html) [Accessed August 19, 2019]"},{"key":"b2","article-title":"Alliance for Proton Therapy Access: Cancer Care Denied: The Broken State of Patient Access to Proton Therapy","unstructured":"Alliance for Proton Therapy Access: Cancer Care Denied: The Broken State of Patient Access to Proton Therapy (https:\/\/allianceforprotontherapy.org\/cancer-care-denied\/) [Accessed August 19, 2019]"},{"key":"b3","series-title":"Crit Rev Oncol Hematol","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.critrevonc.2016.12.002","article-title":"ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review","volume":"110","author":"Andritsch E","year":"2017","unstructured":"Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, : ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol 110:94\u2013105, 20172810940910.1016\/j.critrevonc.2016.12.002"},{"key":"b4","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/s00586-018-5764-0","article-title":"Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival","volume":"27","author":"Bakker SH","year":"2018","unstructured":"Bakker SH, Jacobs WCH, Pondaag W, Gelderblom H, Nout RA, Dijkstra PDS, : Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival. Eur Spine J 27:3043\u20133058, 20183022004210.1007\/s00586-018-5764-0"},{"key":"b5","series-title":"Ann Oncol","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay JY","year":"2017","unstructured":"Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, : Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol 28:2852\u20132859, 20172911733510.1093\/annonc\/mdx484"},{"key":"b6","series-title":"J Am Coll Surg","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jamcollsurg.2016.11.011","article-title":"Impact of facility type and surgical volume on 10-year survival in patients undergoing hepatic resection for hepatocellular carcinoma","volume":"224","author":"Chapman BC","year":"2017","unstructured":"Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, : Impact of facility type and surgical volume on 10-year survival in patients undergoing hepatic resection for hepatocellular carcinoma. J Am Coll Surg 224:362\u2013372, 201710.1016\/j.jamcollsurg.2016.11.01127923615"},{"key":"b7","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"E930","DOI":"10.1097\/BRS.0b013e318296e7d7","article-title":"Definitive high-dose photon\/proton radiotherapy for unresected mobile spine and sacral chordomas","volume":"38","author":"Chen YL","year":"2013","unstructured":"Chen YL, Liebsch N, Kobayashi W, Goldberg S, Kirsch D, Calkins G, : Definitive high-dose photon\/proton radiotherapy for unresected mobile spine and sacral chordomas. Spine (Phila Pa 1976) 38:E930\u2013E936, 201310.1097\/BRS.0b013e318296e7d7"},{"key":"b8","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijrobp.2008.08.058","article-title":"Phase II study of high-dose photon\/proton radiotherapy in the management of spine sarcomas","volume":"74","author":"DeLaney TF","year":"2009","unstructured":"DeLaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, : Phase II study of high-dose photon\/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74:732\u2013739, 20091909537210.1016\/j.ijrobp.2008.08.058"},{"key":"b9","series-title":"J Surg Oncol","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jso.23617","article-title":"Long-term results of Phase II study of high dose photon\/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas","volume":"110","author":"DeLaney TF","year":"2014","unstructured":"DeLaney TF, Liebsch NJ, Pedlow FX, Adams J, Weyman EA, Yeap BY, : Long-term results of Phase II study of high dose photon\/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol 110:115\u2013122, 20142475287810.1002\/jso.23617"},{"key":"b10","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00701-017-3409-4","article-title":"Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma","volume":"160","author":"Freeman JL","year":"2018","unstructured":"Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, : Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien) 160:731\u2013740, 201810.1007\/s00701-017-3409-4"},{"key":"b11","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3171\/2015.7.SPINE15201","article-title":"Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database","volume":"24","author":"Gokaslan ZL","year":"2016","unstructured":"Gokaslan ZL, Zadnik PL, Sciubba DM, Germscheid N, Goodwin CR, Wolinsky JP, : Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. J Neurosurg Spine 24:644\u2013651, 20162668260110.3171\/2015.7.SPINE15201"},{"key":"b12","series-title":"Acta Orthop Scand","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/17453679408993717","article-title":"Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients","volume":"65","author":"Gustafson P","year":"1994","unstructured":"Gustafson P, Dreinh\u00f6fer KE, Rydholm A: Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 65:47\u201350, 199410.3109\/17453679408993717"},{"key":"b13","series-title":"Orthop Clin North Am","first-page":"417","article-title":"Chordoma: a critical review of diagnosis and treatment","volume":"20","author":"Healey JH","year":"1989","unstructured":"Healey JH, Lane JM: Chordoma: a critical review of diagnosis and treatment. Orthop Clin North Am 20:417\u2013426, 19892662114"},{"key":"b14","series-title":"Clin J Oncol Nurs","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1188\/15.CJON.308-313","article-title":"Systematic review of oncology nurse practitioner navigation metrics","volume":"19","author":"Johnson F","year":"2015","unstructured":"Johnson F: Systematic review of oncology nurse practitioner navigation metrics. Clin J Oncol Nurs 19:308\u2013313, 201510.1188\/15.CJON.308-31326000581"},{"key":"b15","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00586-006-0188-7","article-title":"Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry","volume":"16","author":"Kelley SP","year":"2007","unstructured":"Kelley SP, Ashford RU, Rao AS, Dickson RA: Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry. Eur Spine J 16:405\u2013409, 20071686537610.1007\/s00586-006-0188-7"},{"key":"b16","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijrobp.2014.02.014","article-title":"Proton therapy expansion under current United States reimbursement models","volume":"89","author":"Kerstiens J","year":"2014","unstructured":"Kerstiens J, Johnstone PA: Proton therapy expansion under current United States reimbursement models. Int J Radiat Oncol Biol Phys 89:235\u2013240, 20142468515210.1016\/j.ijrobp.2014.02.014"},{"key":"b17","series-title":"HPB (Oxford)","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.hpb.2018.10.019","article-title":"Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"21","author":"Lam A","year":"2019","unstructured":"Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, : Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma. HPB (Oxford) 21:849\u2013856, 201910.1016\/j.hpb.2018.10.019"},{"key":"b18","series-title":"Clin Orthop Relat Res","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/01.blo.0000533623.60399.1b","article-title":"Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers?","volume":"477","author":"Lazarides AL","year":"2019","unstructured":"Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG III, : Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clin Orthop Relat Res 477:718\u2013727, 201910.1097\/01.blo.0000533623.60399.1b30485258"},{"key":"b19","series-title":"Medicine (Baltimore)","doi-asserted-by":"publisher","first-page":"e13445","DOI":"10.1097\/MD.0000000000013445","article-title":"Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: a systematic review and meta-analysis","volume":"97","author":"Lee B","year":"2018","unstructured":"Lee B, Kim K, Park Y, Lim MC, Bristow RE: Impact of hospital care volume on clinical outcomes of laparoscopic radical hysterectomy for cervical cancer: a systematic review and meta-analysis. Medicine (Baltimore) 97:e13445, 201810.1097\/MD.0000000000013445"},{"key":"b20","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2106\/JBJS.J.01784","article-title":"Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry","volume":"94","author":"Lee J","year":"2012","unstructured":"Lee J, Bhatia NN, Hoang BH, Ziogas A, Zell JA: Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. J Bone Joint Surg Am 94:356\u2013363, 201210.2106\/JBJS.J.01784"},{"key":"b21","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/cncr.30689","article-title":"Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate","volume":"123","author":"Mackay CB","year":"2017","unstructured":"Mackay CB, Antonelli KR, Bruinooge SS, Saint Onge JM, Ellis SD: Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate. Cancer 123:2893\u20132900, 20172833443810.1002\/cncr.30689"},{"key":"b22","series-title":"Cancer Causes Control","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1008947301735","article-title":"Chordoma: incidence and survival patterns in the United States, 1973\u20131995","volume":"12","author":"McMaster ML","year":"2001","unstructured":"McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM: Chordoma: incidence and survival patterns in the United States, 1973\u20131995. Cancer Causes Control 12:1\u201311, 200110.1023\/A:100894730173511227920"},{"key":"b23","series-title":"Semin Oncol Nurs","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.soncn.2013.02.005","article-title":"Oncology nurse navigators and the continuum of cancer care","volume":"29","author":"McMullen L","year":"2013","unstructured":"McMullen L: Oncology nurse navigators and the continuum of cancer care. Semin Oncol Nurs 29:105\u2013117, 201310.1016\/j.soncn.2013.02.00523651680"},{"key":"b24","series-title":"Cancer Med","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1002\/cam4.1756","article-title":"Patient choice for high-volume center radiation impacts head and neck cancer outcome","volume":"7","author":"Naghavi AO","year":"2018","unstructured":"Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Venkat PS, Ahmed KA, : Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med 7:4964\u20134979, 20183017551210.1002\/cam4.1756"},{"key":"b25","series-title":"Radiol Med (Torino)","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11547-013-0345-0","article-title":"Proton beam radiotherapy: report of the first ten patients treated at the \u201cCentro Nazionale di Adroterapia Oncologica (CNAO)\u201d for skull base and spine tumours","volume":"119","author":"Orecchia R","year":"2014","unstructured":"Orecchia R, Vitolo V, Fiore MR, Fossati P, Iannalfi A, Vischioni B, : Proton beam radiotherapy: report of the first ten patients treated at the \u201cCentro Nazionale di Adroterapia Oncologica (CNAO)\u201d for skull base and spine tumours. Radiol Med (Torino) 119:277\u2013282, 201410.1007\/s11547-013-0345-0"},{"key":"b26","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cncr.31958","article-title":"The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base","volume":"125","author":"Palm RF","year":"2019","unstructured":"Palm RF, Oliver DE, Yang GQ, Abuodeh Y, Naghavi AO, Johnstone PAS: The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base. Cancer 125:642\u2013651, 20193064453810.1002\/cncr.31958"},{"key":"b27","series-title":"Chordomas. Technologies, Techniques and Treatment Strategies","doi-asserted-by":"publisher","DOI":"10.1055\/b-0036-141743","article-title":"Surgical decision making in chordomas","author":"Pamir MN","year":"2017","unstructured":"Pamir MN, Al-Mefty O: Surgical decision making in chordomas, in Pamir MN, Al-Mefty O, Borba LAB (eds): Chordomas. Technologies, Techniques and Treatment Strategies. New York: Thieme, 201710.1055\/b-0036-141743"},{"key":"b28","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ijrobp.2006.08.052","article-title":"Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation","volume":"67","author":"Rutz HP","year":"2007","unstructured":"Rutz HP, Weber DC, Sugahara S, Timmermann B, Lomax AJ, Bolsi A, : Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 67:512\u2013520, 200710.1016\/j.ijrobp.2006.08.05217084540"},{"key":"b29","series-title":"Acta Oncol","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/0284186X.2018.1512755","article-title":"National practice patterns of proton versus photon therapy in the treatment of adult patients with primary brain tumors in the United States","volume":"58","author":"Ryckman JM","year":"2019","unstructured":"Ryckman JM, Ganesan V, Kusi Appiah A, Zhang C, Verma V: National practice patterns of proton versus photon therapy in the treatment of adult patients with primary brain tumors in the United States. Acta Oncol 58:66\u201373, 201910.1080\/0284186X.2018.151275530280620"},{"key":"b30","series-title":"Eur J Surg Oncol","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejso.2017.12.012","article-title":"Centers of excellence or excellence networks: the surgical challenge and quality issues in rare cancers","volume":"45","author":"Sandrucci S","year":"2019","unstructured":"Sandrucci S, Naredi P, Bonvalot S: Centers of excellence or excellence networks: the surgical challenge and quality issues in rare cancers. Eur J Surg Oncol 45:19\u201321, 201910.1016\/j.ejso.2017.12.01229395437"},{"key":"b31","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S1470-2045(14)71190-8","article-title":"Building a global consensus approach to chordoma: a position paper from the medical and patient community","volume":"16","author":"Stacchiotti S","year":"2015","unstructured":"Stacchiotti S, Sommer J: Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 16:e71\u2013e83, 201510.1016\/S1470-2045(14)71190-825638683"},{"key":"b32","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3171\/2018.6.SPINE18362","article-title":"Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey","volume":"30","author":"Dea N","year":"2018","unstructured":"Dea N, Fisher CG, Reynolds JJ, Schwab JH, Rhines LD, Gokaslan ZL, : Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey. J Neurosurg Spine 30:119\u2013125, 20183049721810.3171\/2018.6.SPINE18362"},{"key":"b33","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1007\/s00586-014-3728-6","article-title":"Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival","volume":"24","author":"Varga PP","year":"2015","unstructured":"Varga PP, Sz\u00f6v\u00e9rfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, : Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24:1092\u20131101, 20152553385710.1007\/s00586-014-3728-6"},{"key":"b34","article-title":"Washington State Health Care Authority: Proton Beam Therapy. Final Evidence Report. Final Appraisals Document","unstructured":"Washington State Health Care Authority: Proton Beam Therapy. Final Evidence Report. Final Appraisals Document. March 28, 2014 (https:\/\/icer-review.org\/wp-content\/uploads\/2014\/07\/pbt_final_report_040114.pdf) [Accessed August 19, 2019]"},{"key":"b35","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","article-title":"Osteosarcoma, chondrosarcoma, and chordoma","volume":"36","author":"Whelan JS","year":"2018","unstructured":"Whelan JS, Davis LE: Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol 36:188\u2013193, 201810.1200\/JCO.2017.75.174329220289"},{"key":"b36","series-title":"J Surg Oncol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.10320","article-title":"The National Cancer Data Base: a clinical surveillance and quality improvement tool","volume":"85","author":"Winchester DP","year":"2004","unstructured":"Winchester DP, Stewart AK, Bura C, Jones RS: The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 85:1\u20133, 20041469608010.1002\/jso.10320"},{"key":"b37","series-title":"Dis Colon Rectum","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/DCR.0000000000000924","article-title":"Is the distance worth it? Patients with rectal cancer traveling to high-volume centers experience improved outcomes","volume":"60","author":"Xu Z","year":"2017","unstructured":"Xu Z, Becerra AZ, Justiniano CF, Boodry CI, Aquina CT, Swanger AA, : Is the distance worth it? Patients with rectal cancer traveling to high-volume centers experience improved outcomes. Dis Colon Rectum 60:1250\u20131259, 20172911256010.1097\/DCR.0000000000000924"},{"key":"b38","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1016\/j.wneu.2018.02.109","article-title":"Chordomas of the skull base, mobile spine, and sacrum: an epidemiologic investigation of presentation, treatment, and survival","volume":"113","author":"Zuckerman SL","year":"2018","unstructured":"Zuckerman SL, Bilsky MH, Laufer I: Chordomas of the skull base, mobile spine, and sacrum: an epidemiologic investigation of presentation, treatment, and survival. World Neurosurg 113:e618\u2013e627, 201810.1016\/j.wneu.2018.02.10929486315"}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/32\/2\/article-p311.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/32\/2\/article-p311.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/32\/2\/article-p311.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T22:47:41Z","timestamp":1681598861000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/32\/2\/article-p311.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2019.7.spine19566","relation":{},"ISSN":["1547-5654"],"issn-type":[{"value":"1547-5654","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}